Is there an Indian version of Pemetinib/Pemetinib?

Pemigatinib/ Pemigatinib is a drug used to treat certain types of cancer. According to our knowledge, there is currently no Indian version of the original or generic version of pemetinib. The original version of pemetinib currently marketed at home and abroad is the American version of Incyte, and the generic version of the drug marketed overseas is the Laos Lucius Pharmaceutical version. The ingredients are basically the same, but there may be differences in price, quality, packaging, and sales channels.

Pemetinib is the first prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with cholangiocarcinoma that has spread or cannot be removed with surgery, has been previously treated, and whose tumors have a certain type of abnormal FGFR2 gene. Healthcare providers will test the patient's cancer to see if a certain type of abnormal FGFR2 gene is present and make sure pemetinib is appropriate for the patient. It is not known whether pemetinib is safe and effective in children. Pemetinib is approved based on tumor response and duration of response. Studies are ongoing to show whether pemetinib improves survival or symptoms. Pemetinib is not chemotherapy; it is a targeted treatment for cholangiocarcinoma.

However, despite the efficacy of pemetinib, patients may have questions about its price. For many patients, the cost of this drug is undoubtedly a heavy burden. The price of original research drugs sold in China may be RMB 30,000 to RMB 50,000, and they are not covered by medical insurance. The price of those sold overseas may be 7About 10,000 yuan (the price may fluctuate due to the exchange rate);The price of generic drugs may be More than 1,000RMB (the price may fluctuate due to the exchange rate).